Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bed Bath & Beyond (BBBY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Bed Bath & Beyond (BBBY) over the last 17 years, with Q3 2025 value amounting to $167.4 million.

  • Bed Bath & Beyond's Cash & Equivalents rose 1923.12% to $167.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.4 million, marking a year-over-year increase of 1923.12%. This contributed to the annual value of $159.2 million for FY2024, which is 4740.04% down from last year.
  • Latest data reveals that Bed Bath & Beyond reported Cash & Equivalents of $167.4 million as of Q3 2025, which was up 1923.12% from $120.6 million recorded in Q2 2025.
  • Bed Bath & Beyond's 5-year Cash & Equivalents high stood at $536.4 million for Q2 2021, and its period low was $114.6 million during Q1 2025.
  • Its 5-year average for Cash & Equivalents is $332.2 million, with a median of $342.9 million in 2023.
  • Per our database at Business Quant, Bed Bath & Beyond's Cash & Equivalents soared by 27857.57% in 2021 and then tumbled by 5686.67% in 2024.
  • Quarter analysis of 5 years shows Bed Bath & Beyond's Cash & Equivalents stood at $503.3 million in 2021, then dropped by 26.24% to $371.3 million in 2022, then fell by 18.49% to $302.6 million in 2023, then crashed by 47.4% to $159.2 million in 2024, then increased by 5.15% to $167.4 million in 2025.
  • Its Cash & Equivalents stands at $167.4 million for Q3 2025, versus $120.6 million for Q2 2025 and $114.6 million for Q1 2025.